Spyre Therapeutics Inc
(SYRE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SYRE | AZN | AMGN | GILD | BMY |
| Company | Spyre Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 35.02 | 205.64 | 362.65 | 151.89 | 60.11 |
| High | 37.98 | 206.71 | 370.42 | 156.95 | 60.95 |
| Low | 35.02 | 204.09 | 361.71 | 151.46 | 60.02 |
| Latest | 36.63 | 205.55 | 369.19 | 154.98 | 60.74 |
| Change | +1.79 | +1.03 | +2.99 | +3.17 | +0.88 |
| % Change | +5.14% | +0.50% | +0.82% | +2.09% | +1.47% |
| Volume | 1,320,000 | 2,504,802 | 2,413,600 | 6,861,800 | 10,819,132 |
| 20-Day Average Volume | 585,065 | 4,517,170 | 3,213,065 | 8,929,335 | 13,678,010 |
| Previous Close | 34.84 | 204.52 | 366.20 | 151.81 | 59.86 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 33.53 | 189.62 | 353.45 | 142.05 | 57.04 |
| 20-Day Raw Stochastic | 80.88% | 95.95% | 74.88% | 93.44% | 84.60% |
| 20-Day Relative Strength | 62.23 | 65.52 | 61.52 | 69.29 | 66.20 |
| Weighted Alpha | +115.54 | +49.13 | +33.73 | +59.72 | +24.36 |
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 64% Buy | 72% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.30% since 02/06/26 | +6.49% since 02/06/26 | -3.94% since 02/06/26 | +1.63% since 02/06/26 | -2.02% since 02/06/26 |
| Low | 32.35 on 02/11/26 | 187.06 on 02/09/26 | 361.00 on 02/11/26 | 147.07 on 02/10/26 | 59.25 on 02/12/26 |
| High | 37.98 on 02/13/26 | 206.71 on 02/13/26 | 384.62 on 02/09/26 | 157.29 on 02/11/26 | 61.63 on 02/09/26 |
| 1-Month | |||||
| %Chg | +16.18% since 01/13/26 | +8.75% since 01/13/26 | +13.84% since 01/13/26 | +27.28% since 01/13/26 | +8.62% since 01/13/26 |
| Low | 30.92 on 02/04/26 | 178.08 on 01/21/26 | 321.71 on 01/20/26 | 120.94 on 01/15/26 | 53.54 on 01/21/26 |
| High | 37.98 on 02/13/26 | 206.71 on 02/13/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | +61.86% since 11/13/25 | +15.99% since 11/13/25 | +9.88% since 11/13/25 | +23.79% since 11/13/25 | +24.90% since 11/13/25 |
| Low | 22.13 on 11/14/25 | 176.56 on 11/14/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 37.98 on 02/13/26 | 206.71 on 02/13/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | +110.52% since 08/13/25 | +31.86% since 08/13/25 | +27.60% since 08/13/25 | +29.00% since 08/13/25 | +26.94% since 08/13/25 |
| Low | 14.51 on 09/22/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 37.98 on 02/13/26 | 206.71 on 02/13/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,703,305 | 317,191,712 | 197,191,760 | 188,347,648 | 121,860,176 |
| Shares Outstanding, K | 77,592 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 0 | 54,073,000,000 | 36,751,000,000 | 28,754,000,000 | 48,194,000,000 |
| Annual Net Income | -208,020,000 | 7,035,000,000 | 7,711,000,000 | 480,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,866,000,000 | 7,769,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -11,180,000 | 2,533,000,000 | 1,333,000,000 | 3,052,000,000 | 1,087,000,000 |
| 60-Month Beta | 3.15 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.15 on 11/04/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 02/26/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.28 | 16.78 | 19.12 | 9.74 |